Cargando…

A novel immune-related genes prognosis biomarker for hepatocellular carcinoma

Background: Hepatocellular carcinoma (HCC) is closely associated with the immune microenvironment. To identify the effective population before administering treatment, the establishment of prognostic immune biomarkers is crucial for early HCC diagnosis and treatment. Results: A total of 335 IRGs ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kunpeng, Chen, Xinyi, Jin, Chong, Mo, Jinggang, Jiang, Hao, Yi, Bin, Chen, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834986/
https://www.ncbi.nlm.nih.gov/pubmed/33260154
http://dx.doi.org/10.18632/aging.202173
_version_ 1783642412842745856
author Wang, Kunpeng
Chen, Xinyi
Jin, Chong
Mo, Jinggang
Jiang, Hao
Yi, Bin
Chen, Xiang
author_facet Wang, Kunpeng
Chen, Xinyi
Jin, Chong
Mo, Jinggang
Jiang, Hao
Yi, Bin
Chen, Xiang
author_sort Wang, Kunpeng
collection PubMed
description Background: Hepatocellular carcinoma (HCC) is closely associated with the immune microenvironment. To identify the effective population before administering treatment, the establishment of prognostic immune biomarkers is crucial for early HCC diagnosis and treatment. Results: A total of 335 IRGs identified from 788 overlapping IRGs were associated with the survival of HCC. A prognostic immunoscore model was identified. The Kaplan-Meier survival curves and time-dependent ROC analysis revealed a powerful prognostic performance of immunoscore signature via multi validation. Besides, the immunoscore signature exhibited a better predictive power compared to other prognostic signatures. Gene set enrichment analysis showed multiple signaling differences between the high and low immunoscore group. Furthermore, immunoscore was significantly associated with multiple immune cells and immune infiltration in the tumor microenvironment. Conclusions: We identified the immunoscore as a robust marker for predicting HCC patient survival. Methods: Three sets of immune-related genes (IRGs) were integrated to identify the overlapping IRGs. Weighted gene co-expression network analysis was performed to obtain the survival-related IRGs. Further, the prognostic immunoscore model was constructed via LASSO-penalized Cox regression analysis. Then the prognostic performance of immunoscore was evaluated. In addition, ESTIMATE and CIBERSORT algorithms were applied to explore the relationship between immunoscore and tumor immune microenvironment.
format Online
Article
Text
id pubmed-7834986
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-78349862021-02-03 A novel immune-related genes prognosis biomarker for hepatocellular carcinoma Wang, Kunpeng Chen, Xinyi Jin, Chong Mo, Jinggang Jiang, Hao Yi, Bin Chen, Xiang Aging (Albany NY) Research Paper Background: Hepatocellular carcinoma (HCC) is closely associated with the immune microenvironment. To identify the effective population before administering treatment, the establishment of prognostic immune biomarkers is crucial for early HCC diagnosis and treatment. Results: A total of 335 IRGs identified from 788 overlapping IRGs were associated with the survival of HCC. A prognostic immunoscore model was identified. The Kaplan-Meier survival curves and time-dependent ROC analysis revealed a powerful prognostic performance of immunoscore signature via multi validation. Besides, the immunoscore signature exhibited a better predictive power compared to other prognostic signatures. Gene set enrichment analysis showed multiple signaling differences between the high and low immunoscore group. Furthermore, immunoscore was significantly associated with multiple immune cells and immune infiltration in the tumor microenvironment. Conclusions: We identified the immunoscore as a robust marker for predicting HCC patient survival. Methods: Three sets of immune-related genes (IRGs) were integrated to identify the overlapping IRGs. Weighted gene co-expression network analysis was performed to obtain the survival-related IRGs. Further, the prognostic immunoscore model was constructed via LASSO-penalized Cox regression analysis. Then the prognostic performance of immunoscore was evaluated. In addition, ESTIMATE and CIBERSORT algorithms were applied to explore the relationship between immunoscore and tumor immune microenvironment. Impact Journals 2020-11-26 /pmc/articles/PMC7834986/ /pubmed/33260154 http://dx.doi.org/10.18632/aging.202173 Text en Copyright: © 2020 Wang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Wang, Kunpeng
Chen, Xinyi
Jin, Chong
Mo, Jinggang
Jiang, Hao
Yi, Bin
Chen, Xiang
A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title_full A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title_fullStr A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title_full_unstemmed A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title_short A novel immune-related genes prognosis biomarker for hepatocellular carcinoma
title_sort novel immune-related genes prognosis biomarker for hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834986/
https://www.ncbi.nlm.nih.gov/pubmed/33260154
http://dx.doi.org/10.18632/aging.202173
work_keys_str_mv AT wangkunpeng anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT chenxinyi anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT jinchong anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT mojinggang anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT jianghao anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT yibin anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT chenxiang anovelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT wangkunpeng novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT chenxinyi novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT jinchong novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT mojinggang novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT jianghao novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT yibin novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma
AT chenxiang novelimmunerelatedgenesprognosisbiomarkerforhepatocellularcarcinoma